Michael P. Mullane

1.5k total citations
13 papers, 58 citations indexed

About

Michael P. Mullane is a scholar working on Cancer Research, Oncology and Genetics. According to data from OpenAlex, Michael P. Mullane has authored 13 papers receiving a total of 58 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cancer Research, 4 papers in Oncology and 4 papers in Genetics. Recurrent topics in Michael P. Mullane's work include Cancer Genomics and Diagnostics (4 papers), Genomics and Rare Diseases (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Michael P. Mullane is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), Genomics and Rare Diseases (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Michael P. Mullane collaborates with scholars based in United States. Michael P. Mullane's co-authors include Michael A. Thompson, James L. Weese, Aaron S. Mansfield, Amanda M. Wilson, Ben Ho Park, Scott M. Weissman, Andrew J. Worth, Huma Q. Rana, Justine A. Barletta and Antônio Marcondes Lerário and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Michael P. Mullane

11 papers receiving 55 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael P. Mullane United States 5 32 18 14 11 11 13 58
Sau-Dan Lee Hong Kong 3 28 0.9× 12 0.7× 34 2.4× 35 3.2× 5 0.5× 5 71
Francesca Guidetti Switzerland 6 14 0.4× 5 0.3× 11 0.8× 22 2.0× 8 0.7× 12 64
M. Sevin Türkiye 4 14 0.4× 24 1.3× 20 1.4× 18 1.6× 23 2.1× 6 78
Tasleema Patel United States 5 9 0.3× 24 1.3× 12 0.9× 10 0.9× 42 3.8× 9 72
Thilo Doerk Germany 4 24 0.8× 23 1.3× 12 0.9× 38 3.5× 5 0.5× 6 76
Hui-Han Hu Taiwan 7 19 0.6× 14 0.8× 33 2.4× 28 2.5× 8 0.7× 7 193
А. В. Султанбаев Russia 4 16 0.5× 7 0.4× 30 2.1× 13 1.2× 3 0.3× 52 63
Ofure Obazee Germany 4 20 0.6× 38 2.1× 26 1.9× 26 2.4× 5 0.5× 5 87
Vinicius S Chagas Brazil 3 17 0.5× 12 0.7× 14 1.0× 32 2.9× 3 0.3× 4 53
Xuetao Shi China 6 12 0.4× 23 1.3× 22 1.6× 14 1.3× 5 0.5× 18 86

Countries citing papers authored by Michael P. Mullane

Since Specialization
Citations

This map shows the geographic impact of Michael P. Mullane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael P. Mullane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael P. Mullane more than expected).

Fields of papers citing papers by Michael P. Mullane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael P. Mullane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael P. Mullane. The network helps show where Michael P. Mullane may publish in the future.

Co-authorship network of co-authors of Michael P. Mullane

This figure shows the co-authorship network connecting the top 25 collaborators of Michael P. Mullane. A scholar is included among the top collaborators of Michael P. Mullane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael P. Mullane. Michael P. Mullane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Owen, Dwight H., Nofisat Ismaila, Jill Feldman, et al.. (2025). Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.3. Journal of Clinical Oncology. 43(10). e2–e16. 4 indexed citations
2.
Hallmeyer, Sigrun, et al.. (2023). Characteristics of patients with hematologic malignancies without seroconversion post-COVID-19 third vaccine dosing. Biology Methods and Protocols. 8(1). bpad002–bpad002. 1 indexed citations
3.
Couvillon, Anna, Barış Türkbey, Peter L. Choyke, et al.. (2023). Inherited risk for prostate cancer (PCa): Following the natural history of men with high-risk genetics using multiparametric MRI (mpMRI).. Journal of Clinical Oncology. 41(6_suppl). 390–390. 1 indexed citations
4.
Weese, James L., et al.. (2022). Quantifying the Value of the Molecular Tumor Board: Discordance Recommendation Rate and Drug Cost Avoidance. JCO Precision Oncology. 6(6). e2200132–e2200132. 4 indexed citations
5.
Thompson, Michael A., et al.. (2022). Real-World Third COVID-19 Vaccine Dosing and Antibody Response in Patients With Hematologic Malignancies. SHILAP Revista de lepidopterología. 9(3). 149–157. 6 indexed citations
6.
Mullane, Michael P., et al.. (2022). Abstract P3-14-17: Exploring racial disparities in BRCA testing for triple negative breast cancer patients: A real-world data analysis. Cancer Research. 82(4_Supplement). P3–14. 1 indexed citations
7.
Hanson, Kristen, Michael P. Mullane, Dean C. Pavlick, et al.. (2021). Identification of potential germline (GL) variants by routine clinical comprehensive genomic profiling (CGP) and confirmatory GL testing in 24 tumor types.. Journal of Clinical Oncology. 39(15_suppl). 10596–10596. 2 indexed citations
8.
Thompson, Michael A., Michael P. Mullane, Amanda M. Wilson, et al.. (2019). Coordinating an Oncology Precision Medicine Clinic Within an Integrated Health System: Lessons Learned in Year One. SHILAP Revista de lepidopterología. 6(1). 36–45. 6 indexed citations
9.
Mansfield, Aaron S., Ben Ho Park, & Michael P. Mullane. (2018). Identification, Prioritization, and Treatment of Mutations Identified by Next-Generation Sequencing. American Society of Clinical Oncology Educational Book. 38(38). 873–880. 5 indexed citations
10.
Thompson, Michael A., et al.. (2017). Multiple Myeloma Baseline Immunoglobulin G Level and Pneumococcal Vaccination Antibody Response. SHILAP Revista de lepidopterología. 4(3). 131–135.
11.
Thompson, Michael A., et al.. (2017). Implementing an oncology precision medicine clinic in a large community health system.. PubMed. 23(10 Spec No.). SP425–SP427. 7 indexed citations
12.
Else, Tobias, Antônio Marcondes Lerário, Jessica N. Everett, et al.. (2017). Adrenocortical carcinoma and succinate dehydrogenase gene mutations: an observational case series. European Journal of Endocrinology. 177(5). 439–444. 21 indexed citations
13.
Mullane, Michael P.. (2014). The Molecular Biology and Treatment of Malignant Melanoma with BRAFV600 Mutations. SHILAP Revista de lepidopterología. 1(1). 21–26.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sau-Dan Lee Breakdown of academic impact, for papers by Francesca Guidetti Breakdown of academic impact, for papers by M. Sevin Breakdown of academic impact, for papers by Tasleema Patel Breakdown of academic impact, for papers by Thilo Doerk Breakdown of academic impact, for papers by Hui-Han Hu Breakdown of academic impact, for papers by А. В. Султанбаев Breakdown of academic impact, for papers by Ofure Obazee Breakdown of academic impact, for papers by Vinicius S Chagas Breakdown of academic impact, for papers by Xuetao Shi
Rankless by CCL
2026